The growth of the overall Organ Preservation Market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures. In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global market. However, high cost of transplantation is likely to restrain the growth of the market during the forecast period.
The organ preservation market is segmented on the basis of preservation solution, technique, organ type and region. By preservation solution, the transplantable organ preservation & transport market comprises of University of Wisconsin (UW) solution, Custodiol HTK, Perfadex and Others (Euro-Collins & Celsior). In 2016, the University of Wisconsin solution segment is estimated to account for the largest share of the transplantable organ preservation & transport market and is expected to grow at the highest rate during the forecast period. This large share can be attributed to its prolific usage in the storage of kidney, liver, and pancreas, better transplantation outcomes, less histological damage, and improved physiological function of organs.
By technique, organ preservation market comprises static cold storage, hypothermic machine perfusion and normothermic machine perfusion. In 2016, the static cold storage segment is estimated to account for the largest share of the transplantable organ preservation & transport market and hypothermic machine perfusion is expected to grow at the highest rate during the forecast period. The growth of this segment can be attributed to factors such as better long-term graft survival rates, decreased vasospasm, and ability to provide metabolic support.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915
On the basis of organ type, the transplantable organ preservation & transport market is divided into kidneys, liver, lung, heart and others (Pancreas & Intestine). In 2016, the Kidneys segment is expected to account for the largest share of the market and grow at the highest rate. The growth of this segment can be attributed to factors such as rising cases of kidney failure, improvements in graft survival, and long-term graft function
On the basis of region, the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the organ preservation market. Its large share can be attributed to growing cases of kidney failure, rising organ transplants, favorable reimbursements scenario within some provinces in Canada, and novel technological advancements by U.S. players. However, the Asia-Pacific market is slated to grow at the highest CAGR during the forecast period due to the new regulatory framework in China, and increasing organ donations in Asia-Pacific and serve as a revenue pocket for companies offering organ preservation solutions and transport systems
The major players in the organ preservation market include Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), and Waters Medical Systems LLC (U.S.), among others.
Target Audience:
# Preservation Solutions and Devices Providers
# Life Sciences Companies
# Medical Device Manufacturers
# Market Research and Consulting Firms
# Healthcare Service Providers
# Medical Research Institutes
# Regulatory Bodies
# Venture Capitalists
Read More@
https://www.marketsandmarkets.com/PressReleases/organ-preservation.asp
No comments:
Post a Comment